NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

New Herceptin study > new hype

Posted By

Tags

Herceptin has been used to treat advanced breast cancer, but three New England Journal of Medicine articles this week suggest the drug could work against an aggressive early-stage breast cancer.

Some news stories allow researchers (including a National Cancer Institute researcher) to use words like “cure” in describing the drug. Other experts were quoted calling the latest studies on the drug “revolutionary…stunning…jaw-dropping.” And some stories didn’t challenge those claims or that language.

But Rita Rubin of USA Today included caution in her story: “Barbara Brenner of Breast Cancer Action, an education and advocacy group, called use of the word ‘cure’ in this case ‘outrageous,’ because the studies on average followed women for only a year or two.”

In the San Jose Mercury News, Brenner was quoted again: “The annals of breast cancer are filled with stories like this one in which the hype hurts thousands of women and their loved ones.”

Jeff Donn of the Associated Press had a quote in his story: “I think it’s way too soon to talk about a cure,” said Debbie Saslow, director of the breast cancer section of the American Cancer Society.”

Good science doesn’t need hype. Good drugs need to stand the test of time. Thank goodness some journalists are countering the hype that they’re encountering and concentrating more on evidence than emotion and excitement.

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.